Glutamatergic Mechanisms: Aim2

NCT05401227 · clinicaltrials.gov ↗
PHASE1
Phase
SUSPENDED
Status
120
Enrollment
OTHER
Sponsor class

Stopped U.S. Department of Health and Human Services OHRP issued an FWA restriction on NYSPI research that included a pause of human subjects research as of June 23, 2023. This study will resume recruitment after OHRP has approved the resumption of research.

Conditions

Interventions

Sponsor

New York State Psychiatric Institute

Collaborators